科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/08 | 3,720 | 3,755 | 3,700 | 3,720 | +25 | +0.7% | 79,500 |
| 2022/11/07 | 3,715 | 3,715 | 3,685 | 3,695 | -5 | -0.1% | 59,700 |
| 2022/11/04 | 3,750 | 3,760 | 3,695 | 3,700 | -80 | -2.1% | 91,800 |
| 2022/11/02 | 3,765 | 3,785 | 3,730 | 3,780 | +20 | +0.5% | 162,400 |
| 2022/11/01 | 3,800 | 3,810 | 3,760 | 3,760 | -45 | -1.2% | 58,300 |
| 2022/10/31 | 3,780 | 3,810 | 3,765 | 3,805 | +50 | +1.3% | 110,700 |
| 2022/10/28 | 3,745 | 3,805 | 3,740 | 3,755 | -30 | -0.8% | 250,100 |
| 2022/10/27 | 3,805 | 3,805 | 3,760 | 3,785 | ±0 | ±0% | 59,900 |
| 2022/10/26 | 3,760 | 3,800 | 3,750 | 3,785 | +50 | +1.3% | 53,700 |
| 2022/10/25 | 3,720 | 3,750 | 3,720 | 3,735 | +30 | +0.8% | 65,500 |
| 2022/10/24 | 3,780 | 3,780 | 3,705 | 3,705 | -60 | -1.6% | 69,700 |
| 2022/10/21 | 3,775 | 3,790 | 3,750 | 3,765 | -35 | -0.9% | 36,300 |
| 2022/10/20 | 3,800 | 3,815 | 3,780 | 3,800 | -30 | -0.8% | 47,900 |
| 2022/10/19 | 3,880 | 3,880 | 3,810 | 3,830 | -20 | -0.5% | 46,500 |
| 2022/10/18 | 3,840 | 3,865 | 3,820 | 3,850 | +60 | +1.6% | 78,200 |
| 2022/10/17 | 3,825 | 3,830 | 3,790 | 3,790 | -40 | -1% | 44,200 |
| 2022/10/14 | 3,840 | 3,855 | 3,775 | 3,830 | +60 | +1.6% | 80,300 |
| 2022/10/13 | 3,760 | 3,785 | 3,740 | 3,770 | -10 | -0.3% | 80,800 |
| 2022/10/12 | 3,780 | 3,810 | 3,765 | 3,780 | -15 | -0.4% | 72,400 |
| 2022/10/11 | 3,800 | 3,825 | 3,760 | 3,795 | -45 | -1.2% | 84,600 |
| 2022/10/07 | 3,810 | 3,855 | 3,790 | 3,840 | -20 | -0.5% | 59,400 |
| 2022/10/06 | 3,890 | 3,905 | 3,850 | 3,860 | -5 | -0.1% | 71,600 |
| 2022/10/05 | 3,920 | 3,920 | 3,845 | 3,865 | -35 | -0.9% | 104,700 |
| 2022/10/04 | 3,835 | 3,900 | 3,835 | 3,900 | +130 | +3.4% | 113,800 |
| 2022/10/03 | 3,785 | 3,785 | 3,740 | 3,770 | -45 | -1.2% | 78,300 |
| 2022/09/30 | 3,815 | 3,860 | 3,805 | 3,815 | +15 | +0.4% | 107,200 |
| 2022/09/29 | 3,745 | 3,810 | 3,715 | 3,800 | +15 | +0.4% | 107,700 |
| 2022/09/28 | 3,730 | 3,795 | 3,720 | 3,785 | +40 | +1.1% | 87,700 |
| 2022/09/27 | 3,745 | 3,775 | 3,740 | 3,745 | -10 | -0.3% | 79,700 |
| 2022/09/26 | 3,740 | 3,800 | 3,740 | 3,755 | -25 | -0.7% | 85,400 |
| 2022/09/22 | 3,770 | 3,790 | 3,750 | 3,780 | -35 | -0.9% | 48,000 |
| 2022/09/21 | 3,830 | 3,835 | 3,800 | 3,815 | -40 | -1% | 44,800 |
| 2022/09/20 | 3,890 | 3,895 | 3,845 | 3,855 | +15 | +0.4% | 56,900 |
| 2022/09/16 | 3,815 | 3,850 | 3,815 | 3,840 | -10 | -0.3% | 67,100 |
| 2022/09/15 | 3,845 | 3,860 | 3,825 | 3,850 | +5 | +0.1% | 35,500 |
| 2022/09/14 | 3,855 | 3,875 | 3,840 | 3,845 | -80 | -2% | 52,500 |
| 2022/09/13 | 3,910 | 3,930 | 3,890 | 3,925 | +30 | +0.8% | 43,900 |
| 2022/09/12 | 3,930 | 3,930 | 3,880 | 3,895 | -5 | -0.1% | 41,500 |
| 2022/09/09 | 3,850 | 3,915 | 3,850 | 3,900 | +40 | +1% | 75,800 |
| 2022/09/08 | 3,820 | 3,860 | 3,795 | 3,860 | +90 | +2.4% | 84,500 |
| 2022/09/07 | 3,780 | 3,780 | 3,735 | 3,770 | -15 | -0.4% | 65,400 |
| 2022/09/06 | 3,800 | 3,830 | 3,785 | 3,785 | -25 | -0.7% | 50,500 |
| 2022/09/05 | 3,795 | 3,815 | 3,770 | 3,810 | -10 | -0.3% | 57,300 |
| 2022/09/02 | 3,810 | 3,830 | 3,780 | 3,820 | ±0 | ±0% | 78,300 |
| 2022/09/01 | 3,850 | 3,865 | 3,800 | 3,820 | -50 | -1.3% | 71,300 |
| 2022/08/31 | 3,825 | 3,880 | 3,825 | 3,870 | ±0 | ±0% | 48,300 |
| 2022/08/30 | 3,850 | 3,885 | 3,840 | 3,870 | +25 | +0.7% | 33,600 |
| 2022/08/29 | 3,795 | 3,855 | 3,790 | 3,845 | -20 | -0.5% | 57,400 |
| 2022/08/26 | 3,915 | 3,915 | 3,855 | 3,865 | -35 | -0.9% | 46,500 |
| 2022/08/25 | 3,900 | 3,920 | 3,880 | 3,900 | ±0 | ±0% | 53,200 |
601～
650
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 410,900円 | +30.5% | +111.0% | 4.62% | 11.58倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 住友ファーマ | 62,700円 | +21.1% | - | 0.00% | 15.57倍 | 2.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 187,600円 | +5.0% | +1.5% | 0.00% | 16.10倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 378,000円 | +14.5% | -2.3% | 2.38% | 13.83倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 227,800円 | - | - | 0.00% | - | 105.51倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
